drugset / Trial / NCT03478020
Oral AQX-1125 and Combination Oral Contraceptive Drug-Drug Interaction Study
SequentialOpen-labelTreatment
Summary
This is an open-label, fixed sequence, 4 cycle, drug-drug interaction (DDI) study of AQX-1125 in healthy female subjects on combination oral contraceptives (COC).
Timeline
- Start
- 2017-11-22
- Primary completion
- 2018-03-29
- Completion
- 2018-04-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Levonorgestrel | Small molecule | 100 ug | Oral |
| Subject | ROSIPTOR | Small molecule | 200 mg | Oral |
| Subject | ethinyl estradiol | Small molecule | 20 ug | Oral |
Indications
No indication recorded.